
        <!DOCTYPE html>
        <html>
        <head>
            <title>Pfizer Inc. (PFE) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Pfizer Inc. (PFE)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">202</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">114</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">38</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.21</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d" target="_blank" rel="noopener noreferrer">Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-05</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1b46c276c9a6bdd7526e0c028923cb36b72866a7c37c090cadcd299ea5b93d80" target="_blank" rel="noopener noreferrer">Down 34%, Should You Buy the Dip on Viking Therapeutics?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.20
                                </span>
                            </div>
                            <div class="article-summary">Viking aims to enter the billion-dollar weight loss drug market....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a6a45a788f14fa2a929688b7af67c84f0f222811d44466e6fe01f0cd214787cd" target="_blank" rel="noopener noreferrer">Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.83
                                </span>
                            </div>
                            <div class="article-summary">The global lyophilized injectable drugs market is set to grow at a 14.0% CAGR from 2025 to 2033, driven by rising demand for stable parenteral medications and expansion in oncology and infectious dise...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2213766ccce6b9991bf12bc13becc1057b10ad016cb0cd3e8c42d37379899bca" target="_blank" rel="noopener noreferrer">3 Things You Need to Know if You Buy Pfizer Today</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Pfizer has a lofty 6.9% dividend yield, but is it the only or best choice for investors interested in the pharma space?...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=97c3c62d1edeefc351005a04053c765bcb576513dbc32a8ff9c6cb39c16cef37" target="_blank" rel="noopener noreferrer">2 Top Dividend Stocks to Buy With Less Than $50</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">These stocks are cheap in more ways than one....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8dfaf59caf98d7f367cb425931200b3371f73415da613fc490f94620373c357d" target="_blank" rel="noopener noreferrer">Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.28
                                </span>
                            </div>
                            <div class="article-summary">BOULDER, Colo., September 04, 2025--Enveda raises $150M Series D, reaches unicorn status, enrolls first patient in clinical trials, and adds former Pfizer CSO Mikael Dolsten to board....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0124393ccb36eeb8291d3e6b7bd4f6272f11f4b748de403052e6727dbb81deb3" target="_blank" rel="noopener noreferrer">Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">The Australia Acute Respiratory Distress Syndrome (ARDS) Market is forecasted to grow from USD 24.82 million in 2024 to USD 44.79 million by 2033, with a CAGR of 6.78%. Key drivers include a rising in...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=41acb18718b4d62fe969919f54f9213b7b1a28266bf32db064dfd46afcfcf210" target="_blank" rel="noopener noreferrer">Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-04</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer's strong Q2 results, high dividend yield, and bullish chart fuel optimism despite patent losses and rising competition....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a8a5730ba2e501e9314437e189fcd95d6828f4c15c021bbf80055f56dfbe0a9c" target="_blank" rel="noopener noreferrer">J&J Gears Up for Some Key New Drug Approvals and Launches</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.77
                                </span>
                            </div>
                            <div class="article-summary">JNJ believes 10 of its new products and pipeline candidates can deliver peak sales of $5 billion, including Talvey, Tecvayli, Imaavy, Caplyta and others....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=00f75ba52457ff645b6793c88bbf5da9ab90e34d883df2a57ae877a196cd7917" target="_blank" rel="noopener noreferrer">Pfizer Defends Covid Shot, Says Trump Deserves Nobel Prize</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.43
                                </span>
                            </div>
                            <div class="article-summary">The company is “dedicated to continuing to provide clear, factual data to the public,” Pfizer Chief Executive Officer Albert Bourla said in the statement, adding that data on Pfizer’s Covid shot has b...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cac5c4168cd6b720cd7c89c8c6b52351b8e05275a52cc6b37610f0ecffcdaca5" target="_blank" rel="noopener noreferrer">Pfizer (PFE) Partners With Olema For New Metastatic Breast Cancer Study</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.88
                                </span>
                            </div>
                            <div class="article-summary">Pfizer (PFE) recently made headlines with Olema Pharmaceuticals announcing a significant clinical trial collaboration, enhancing their portfolio in the treatment of metastatic breast cancer. Over the ...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a345afdc60a5701997e607845e50e8d54536a76165c1cf11e34840c364702bea" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Retreat Wednesday Afternoon</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index down 0.4% and the H...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3653e24500c574626a4d9e61fabdfa98699d8e685e00a07c4cd6ad43d9afb734" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Decline Late Afternoon</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks retreated late Wednesday afternoon, with the NYSE Health Care Index down 0.3% and...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cd63b24101809bb03272950151373334265f0a5bca8bd003305aaf133af1f30c" target="_blank" rel="noopener noreferrer">Salesforce Reports Record Second Quarter Fiscal 2026 Results</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.81
                                </span>
                            </div>
                            <div class="article-summary">SAN FRANCISCO, September 03, 2025--Salesforce Reports Record Second Quarter Fiscal 2026 Results...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=877a9539bc34b94adc35f6d25b682ee0bebbe1a979608a7d4701c10086151dfb" target="_blank" rel="noopener noreferrer">3 High-Yield Dividend Stocks You Can Buy in September and Hold Forever</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.52
                                </span>
                            </div>
                            <div class="article-summary">With an average yield above 6%, these stocks could do a lot to raise your passive income stream....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e99ce542b38dba73dd8eadd945eb35d6e2c62261fae0c8ba82c6a39deb5c7f7d" target="_blank" rel="noopener noreferrer">Pfizer Inc. (PFE)’s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Pfizer Inc. stands fifth among them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to d...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0688f0c47b84d362d6cacdaf440b978f2dde0a7d027a9c8029e214e7c1d85e9a" target="_blank" rel="noopener noreferrer">How AI advances will shape the drugmaker of the future</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">An AI revolution is taking place, and leaders from tech to Big Pharma are forecasting what drugmakers of the future will look like....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=450fb25356e330dc70b0e0eb95072a60c5647529f95f0b1b8ede3222e24f9930" target="_blank" rel="noopener noreferrer">Pfizer: Pipeline Monetization Shows Great Promise - Rich Yields Pending Re-Rating</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">PFE has shown great efforts in operational efficiencies, as observed in the richer profit margins, the expanding cash flows, and the healthier balance sheet....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=445725da87260704fd9258124660145bc7b28c276175d7269d912c76b492a78a" target="_blank" rel="noopener noreferrer">Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">Study to explore the palazestrant-atirmociclib combination in approximately 35 patients with initiation anticipated in H2 2025 Results to inform potential pivotal Phase 3 trial of novel combination in...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9862a39812bb2317d14fde86a66fa02a1b951c7c0ece925d708b2783254e38f1" target="_blank" rel="noopener noreferrer">Is Pfizer Stock Underperforming the Nasdaq?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.19
                                </span>
                            </div>
                            <div class="article-summary">Although Pfizer has underperformed the Nasdaq recently, analysts remain moderately optimistic about the stock’s prospects....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=33c9ebbab7aeb6d59e547832b4b661f2535bd8fb6e6c7545c0a056616208f8ff" target="_blank" rel="noopener noreferrer">Nicotine Gum Market Report 2025-2033 | Competitive Analysis of British American Tobacco, Cambrex, GlaxoSmithKline, ITC, Johnson & Johnson, Novartis, Perrigo, Pfizer, and Takeda</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The nicotine gum market is driven by smoking cessation initiatives and rising health awareness, leading to increased demand for OTC nicotine therapies. Technological advancements enhance product effic...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=65b2a75f8fb7f17a80f259ca29a6ceed99019487a93def96b25284b726a99e10" target="_blank" rel="noopener noreferrer">Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">CRMD's DefenCath, its only revenue source, posts $78.8M in sales in H1 2025, with exclusivity through 2033 fueling growth potential....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cfb98e89bfb6cc4bf8693527cefe987a6baf1944d47c32d7bcf8af5a0451ba5a" target="_blank" rel="noopener noreferrer">Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1c046a7258d786c22490242969b058f09f7c9de604f2e29101add172cb380fa5" target="_blank" rel="noopener noreferrer">Dividend Income: Lanny's June 2025 Summary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-01</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.42
                                </span>
                            </div>
                            <div class="article-summary">In June, we (my wife and I) received a dividend income total of $5,403.93. We had a booming 4 dividend increases this month...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d6c45500a002fb7fd4832767e4472e4b675022f5d9796420aef2dd4ae5f12b0f" target="_blank" rel="noopener noreferrer">Pfizer's 7% Dividend: Income Gem or Value Trap?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The pharmaceutical giant currently offers a 7% yield, but dividend investors need to look beyond the headline number....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=479e539b22e273eb512fc3916943e0e270a10831bc1b0ebf9c21066e7fee290c" target="_blank" rel="noopener noreferrer">A Look at Pfizer’s Valuation After FDA Approval of Next-Gen COVID Vaccine for Older Adults and High-Risk Groups</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.44
                                </span>
                            </div>
                            <div class="article-summary">If you have been watching Pfizer (PFE), the latest FDA approval is hard to ignore. On August 27, the U.S. Food and Drug Administration gave the green light to Pfizer and BioNTech’s updated COVID-19 va...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=766b7bbe3cfaf3f14842b487bb761254e5a7e1e7add1dbf89f118fba2d7c5ac2" target="_blank" rel="noopener noreferrer">Pfizer's Golden Cross Signals Strength: How to Play the Stock</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer trades above key SMAs with a golden cross, while new drugs and cost cuts drive growth despite looming headwinds....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b53deb6c33ba184870373d4368a1b7dca3f9418e70480353d293d222eb6d9083" target="_blank" rel="noopener noreferrer">Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.72
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. (NYSE:PFE) is one of the top most undervalued low volatility stocks to buy now. Pfizer Inc. (NYSE:PFE) announced on August 27 the US Food and Drug Administration’s (FDA) approval of the su...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d7d49c500aac03068049e36c930b89476a36ae0e2b32058fc9675b5ebc93e8b9" target="_blank" rel="noopener noreferrer">3 No-Brainer Stocks to Buy Right Now</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Investing in these pharmaceutical stocks is an easy decision....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=78b826f2f4929c04d82d57c22204b78156dff72a52c6b812f318654c556f6845" target="_blank" rel="noopener noreferrer">8 'Safer' Dividend Buys In Barron's 23 Better Bets (BBB) Than T-Bills August Report</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-31</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.85
                                </span>
                            </div>
                            <div class="article-summary">Discover 23 top dividend stocks with yields over 4.2%âoffering solid income and growth, even as bond yields rise....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0662f07a31d05278cb660cdf2621d1dc4a73cf29cd67af073f9e563f506cfd9c" target="_blank" rel="noopener noreferrer">Large-cap biotech is a sector to watch for investors: Analysts</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.40
                                </span>
                            </div>
                            <div class="article-summary">Large-cap biotechs are a potential new asset class as China and D.C. pressure Big Pharma to invest elsewhere....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4300ff623ac16d9e348e1ceaef2be1196e21af4483b2639b3dd2a4de1234d66d" target="_blank" rel="noopener noreferrer">Better High-Yielding Dividend Stock: Realty Income vs. Pfizer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">Dividend stocks are a great way for investors to generate passive income....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7d3ef3c89d26a6fff49f002874cfad871cf3214457e54a38923f61bd20dd5601" target="_blank" rel="noopener noreferrer">4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">How does a 7.5% dividend yield sound?...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ad5bc7c564406b5477e1440941587d0745b47f2a1ca89ff84b7b97be5ce1a334" target="_blank" rel="noopener noreferrer">Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.23
                                </span>
                            </div>
                            <div class="article-summary">We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Genmab A/S is one of them. Genmab A/S (NASDAQ:GMAB), based in Copenhagen, is a biotechnology company focused...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cc00f476b770ab27ea7f6bdeb6bae58631954f5e1181a50203abab141ec9727a" target="_blank" rel="noopener noreferrer">If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cd5b0e7f7073f7c6b99befc729473d98b794028f55711773ec7140c00fc76cbf" target="_blank" rel="noopener noreferrer">AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.21
                                </span>
                            </div>
                            <div class="article-summary">AbbVie's strong financial results for the second quarter of 2025 were ensured by its two superstars, Rinvoq and Skyrizi. Click here to read my latest analysis....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=abe38108d466fa485c347af342f37d30be9996f4503123da50d1fd6e84606970" target="_blank" rel="noopener noreferrer">Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.55
                                </span>
                            </div>
                            <div class="article-summary">Boyd Gaming surges on strong earnings and growth plans, while Shoe Carnival struggles with sliding sales and weaker momentum....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4c31394a84f16b0ef95881bb123ec46441f63a90a01cdb13d258c3a0c8ff6e1d" target="_blank" rel="noopener noreferrer">Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q2</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.28
                                </span>
                            </div>
                            <div class="article-summary">As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at branded pharmaceuticals stocks, starting ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e94a5991d8b2690f00b92f09404f407f0a5b65e3dffb42e56aa53fdbf75214e5" target="_blank" rel="noopener noreferrer">8 Ideal 'Safer' Dividend Dogs To Buy From 60 August Graham Value All-Stars</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">8 of 14 'safer' lowest-priced GASV stocks are currently fair-priced and buyable. See here for top large-cap value stocks with strong dividends and intrinsic value....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8ca3056342f51caad5a170c82530b8551ae6923b3b2d4385d9fec05adb38c9f0" target="_blank" rel="noopener noreferrer">Morgan Stanley Lifts Pfizer (PFE) Price Target, Keeps Equalweight Rating</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.85
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. (NYSE:PFE) is one of the 10 Best Affordable Stocks Under $50 to Buy. On August 5, Morgan Stanley increased its price target for Pfizer Inc. (NYSE:PFE) from $32 to $33 while keeping an Equa...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a1b1dc0d835dd47be4680be05e8d64b81b902e5874fbe03722a16b166c217847" target="_blank" rel="noopener noreferrer">Pfizer: A 6% Dividend Yield That Pays You To Stay Defensive</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer stock trades at a multi-year low with a 6.65% dividend yield. Click here for a full investment analysis of PFE stock....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=71c4a70450405f59339de75a962f9c2b670e190fefe4a0451ffcdf6a2370236a" target="_blank" rel="noopener noreferrer">Does Enanta’s EU Lawsuit Over Paxlovid Shift the Bull Case for Pfizer (PFE)?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.52
                                </span>
                            </div>
                            <div class="article-summary">Enanta Pharmaceuticals has filed a patent infringement lawsuit against Pfizer and subsidiaries in the Unified Patent Court of the European Union, alleging that Pfizer’s COVID-19 antiviral Paxlovid inf...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=52bb6444dd51a03066168011e4c4489567a1f5a98e41869e26a85f8637d7f372" target="_blank" rel="noopener noreferrer">FDA approves mRNA vaccines for new Covid-19 season amid political tension</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.20
                                </span>
                            </div>
                            <div class="article-summary">Moderna and Pfizer/BioNTech have secured formula updates to existing mRNA Covid-19 vaccines....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a72c3586afaa7ece6e70f2b2971d4a5c05086bda0c20505f68b074db1b0e3903" target="_blank" rel="noopener noreferrer">Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.88
                                </span>
                            </div>
                            <div class="article-summary">Pfizer braces for patent losses, IRA pressure and COVID uncertainty, but cost cuts and key drugs may still support profit growth....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=86cf60d6e6e33ce10c63e04c72fe20e9b4b243ffba53c2f6ee8489aa45b2e4d5" target="_blank" rel="noopener noreferrer">Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.80
                                </span>
                            </div>
                            <div class="article-summary">ALNY's Amvuttra revenues surge with 89% sales growth in H1 and a key label expansion, but faces tough competition in the ATTR-CM market....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=119d39afa8c3e6bfc439e7a1c59565c9920d3b3ea70ce6bcb3eca2b1e6df90da" target="_blank" rel="noopener noreferrer">MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Merck and Daiichi Sankyo begin dosing in the phase III HERTHENA-Breast04 study on patritumab deruxtecan in certain breast cancer patients....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=441e5e43d762e4bac0a6a43beddabacad1db6db57e99b826e745b7f93e68c615" target="_blank" rel="noopener noreferrer">FDA Approves Updated COVID-19 Vaccines but With Restrictions</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=58bf5e1402e569e017d66b464fcf962c0ba550542701536cb7790d74e69f2b73" target="_blank" rel="noopener noreferrer">Pfizer Inc. stock underperforms Thursday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.93
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. stock underperforms Thursday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=90778682238704c1346b1a79dce13194dd8a184ccad6f2a83a56a2cfbe936527" target="_blank" rel="noopener noreferrer">Taking Profits For Yield And Growth With David Alton Clark</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">David Alton Clark, The Winter Warrior Investor, thinks the market is a little bit toppy, feels good about shorter-term bonds, and is taking profits....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2ae470d97051ba85386ee7c3866cbc534f20b7bebccf7cf3851a377e183f4837" target="_blank" rel="noopener noreferrer">Inside the Trump Administration’s Vaccine Politics</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.37
                                </span>
                            </div>
                            <div class="article-summary">President Trump embraced antivaccine supporters. Now a crisis is unfolding at the Centers for Disease Control and Prevention under RFK Jr....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=77dc9df5cd4ac485649fa3adce84d493276ea01777881d874b79d7f737013cad" target="_blank" rel="noopener noreferrer">Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.88
                                </span>
                            </div>
                            <div class="article-summary">The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market "within months," according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr. Shor...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9d461e0b4d97e55d511f3c6e3d7bd785423f7c2d101af7c9409b9c8f2264c2be" target="_blank" rel="noopener noreferrer">Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.53
                                </span>
                            </div>
                            <div class="article-summary">The global chronic inducible urticaria (CIndU) market is experiencing significant transformation due to rising prevalence, advancements in diagnostics, and targeted immunotherapies. Affecting 0.1% to ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=459030ebf78534849e2c06f68d0a59a57cd09453cecbb0b13f1d5e1fe019216b" target="_blank" rel="noopener noreferrer">Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">Dyslipidemia, linked to elevated cardiovascular disease risk, is benefiting from advancements in lipid profiling and genetic testing, catalyzing demand for personalized treatments. Statins dominate th...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a8346d3c26cee54d1fd947600a13011c313b4937895ae28f0caaab767135e4af" target="_blank" rel="noopener noreferrer">HER2+ Breast Cancer Clinical Trials Analysis Report 2025 - Enhance Your Understanding of Trial Counts and Enrollment Trends Across G7 & E7 Countries</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.20
                                </span>
                            </div>
                            <div class="article-summary">Featuring Roche, Pfizer, GSK, Novartis, and AstraZeneca Among Other Industry PlayersDublin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The "Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0d7fb7dee8f54f0b6063611503ff4a77f6f85988f104bf3aa171a69729c5e295" target="_blank" rel="noopener noreferrer">LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer's cost cuts, new products and cheaper valuation give it an edge over Eli Lilly despite LLY's strong GLP-1 momentum....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2c796354618d49eccc81ddcc0a954695733618eabbafacaba09e3b5a9cf43c4a" target="_blank" rel="noopener noreferrer">ADVANCE 2025 Returns September 17 in New York City Featuring Global CMOs, Big Tech Leaders, and Wyclef Jean</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, August 27, 2025--Smartly, the AI-powered advertising technology platform, today announced the lineup for its flagship event, ADVANCE, on September 17 at Skylight at The Refinery in New York ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5c9c5ad47420d627cfdffdc181bb0a20b74931b5b9a4ee6e4b598a7fe15ffe94" target="_blank" rel="noopener noreferrer">My 3 Favorite Stocks to Buy Right Now</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Contrary to a common assumption at this time, not every stock is priced too richly or poses too much risk. Several underappreciated and undervalued names are just waiting to be found....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=277eef0b1271221f01143c765ef5e97db3e87248c0485139023b0f0823dff71d" target="_blank" rel="noopener noreferrer">Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 27, 2025 / Renovaro Inc. (NASDAQ:RENB) today announced that it will change its corporate name to Lunai Bioworks, Inc. to better reflect its strategic...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=477aa9d681e268075417c12404e833b0beca58a7a7d3c5ba49504e827c7382f1" target="_blank" rel="noopener noreferrer">FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6dd2c50f4ff131f4e4e9576cb60563591f4426ac4f6caf4c37bf354484d278e3" target="_blank" rel="noopener noreferrer">Will Camzyos Strengthen BMY's Cardiovascular Portfolio?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.89
                                </span>
                            </div>
                            <div class="article-summary">Bristol Myers leans on Eliquis and surging Camzyos sales to offset looming generics, while its pipeline candidate milvexian readouts are near....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=aaa36e3a50d3bc27c0ad09c9ef610686abf9f9f53b26fbe91fd0a4bd62392eac" target="_blank" rel="noopener noreferrer">Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.77
                                </span>
                            </div>
                            <div class="article-summary">The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1Shipping of the LP.8.1-adapted vaccine will beg...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ea4e3f36b47db4a3426c20b44d91dbd2e7c27f056f00c0af8318cb2929301611" target="_blank" rel="noopener noreferrer">New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">The Food and Drug Administration approved shots from Pfizer, Moderna and Novavax, but for a narrower population....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ec425284e980cf083d7d06feec4294590bc48a5d33b2fdd798c828b58de26570" target="_blank" rel="noopener noreferrer">Pfizer: Finally Some Fortune, Plus Twenty High-Quality Dividend Growth Valuations</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Discover high-quality dividend-growth stocks near 52-week lows. Explore Pfizer's strong dividend and valuations, plus other top picks like Merck and Qualcomm....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8f7ba892d8bece0a058c5188b3b0edb27df0bd0973d1e91199ed6ff32bd2d027" target="_blank" rel="noopener noreferrer">Unusual Put Option Activity in Pfizer Stock - Have Investors Turned Bearish?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.83
                                </span>
                            </div>
                            <div class="article-summary">Barchart reports that Pfizer stock is showing unusual put option activity in yesterday's trading. Does that mean investors have turned bearish? Not necessarily, especially given the company's upgraded...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5cd95580d17289856d993b9c007e4d390a9e1b2274662960bb75090d5b9887fe" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Advance Wednesday Afternoon</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.75
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Heal...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1a299388f40e08b9bb9af5c91fbd4c1d220613b271a8129aa57f00d003fff393" target="_blank" rel="noopener noreferrer">RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.91
                                </span>
                            </div>
                            <div class="article-summary">BioNTech stock skidded Wednesday after the Food and Drug Administration ended its broad authorization of Covid vaccines in the U.S....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=23c19e1db3fa6aa7aa1650e2689e1f433be52d73522c2ed31b8d5231b86c4102" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Mixed Late Afternoon</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.85
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index adding 0.1%...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=225c9c289c3b805ba5e4f2ae3e9f3eca63c1e619af759877e3ff71213087374f" target="_blank" rel="noopener noreferrer">Is There Now an Opportunity in Pfizer After FDA Covid Vaccine Review for Children?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-26</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.56
                                </span>
                            </div>
                            <div class="article-summary">Thinking about what to do with your Pfizer shares? You are definitely not alone, especially as sentiment around the stock feels conflicted. Over the past week, Pfizer slid a modest 0.7%, and for the y...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=75d9b24c0cd17c7275aa5e8b9b7aa3be07b187254ade510a67a413895da9bcca" target="_blank" rel="noopener noreferrer">GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-26</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Gilead secures EU approval for twice-yearly HIV prevention shot Yeytuo, backed by strong trial data and expanded market protection....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=509b382d9fdd30c8599bc4ca4560579ed5c7abd0af3185e455dbcd034528c304" target="_blank" rel="noopener noreferrer">2 Reasons to Watch ZTS and 1 to Stay Cautious</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">Over the past six months, Zoetis’s shares (currently trading at $156.80) have posted a disappointing 7% loss, well below the S&P 500’s 8.6% gain. This might have investors contemplating their next mov...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fade8cd05123e2a52052d29ef95836709becf227b6bec44edbff90a33cf39a88" target="_blank" rel="noopener noreferrer">Stocks slip on Wall Street after last week's rally</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.95
                                </span>
                            </div>
                            <div class="article-summary">Stocks on Wall Street closed broadly lower Monday, giving back some of the big gains the market notched last week on hopes for interest rate cuts from the Federal Reserve.  The Nasdaq composite closed...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ef4ddda3f0dbf2ab2312eed9c2e9350218a2f35ab69a2e7b7f5d813f53ba6026" target="_blank" rel="noopener noreferrer">[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Targeted Drug Delivery Market size & share revenue was valued at appr...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1bdcaade5654c24219b586d7349df33e06732dbf0a1d5dc7917e5718844d2762" target="_blank" rel="noopener noreferrer">Pfizer Inc. stock underperforms Monday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.92
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. stock underperforms Monday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=06618a13ae3b4cd8594fcf791a3fa5615929b10ed4eb8a273b9a4f90485fec46" target="_blank" rel="noopener noreferrer">Pfizer: Don't Be Fooled By The Dead Cat Bounce</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-24</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Pfizer's diversified pipeline and new product launches are driving operational growth. Click here to read more about PFE stock and why it is rated as a Hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c6e165a75986c60c395421adbb7982d2277eaf8ac8dc4f3c8051e3246bd1909f" target="_blank" rel="noopener noreferrer">Arvinas, Inc. (NASDAQ:ARVN) Stake Jumps 194% at XTX Topco</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.93
                                </span>
                            </div>
                            <div class="article-summary">Arvinas, Inc. (NASDAQ:ARVN) is among the best US stocks under $10 to invest in. XTX Topco Ltd has increased its stake in Arvinas, Inc. (NASDAQ:ARVN) by 194.2% during the first quarter, as disclosed in...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=259428b71e25776a029cb92d302be440f6d92e0e9af664da0ca96d4208a8c484" target="_blank" rel="noopener noreferrer">3 Unstoppable Dividend Stocks to Buy Right Now</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">Investors will get great dividends and more with these stocks....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=67abe8fc633c4608f5fddde7dbc54f0c97affbfe0de3227b0d524131f22fc049" target="_blank" rel="noopener noreferrer">My 5 Favorite Stocks to Buy Right Now</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.43
                                </span>
                            </div>
                            <div class="article-summary">Not every ticker worth owning at this time has raced to an uncomfortably high price....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5a68ebd2e1f002224dadbac608b50cb7f6df768e90c4de79fe70887b6e682f67" target="_blank" rel="noopener noreferrer">Investors Crave Long-Term Debt, But Firms Don’t Want to Sell</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.54
                                </span>
                            </div>
                            <div class="article-summary">When blue-chip companies have sold debt maturing in 30 years or more in the US, they’ve found heavy demand, with money managers placing orders equal to about five times the notes for sale on average. ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a7b2ccc1f9ade8de00401e0212298710d33b7bd95149a5b22a9b9be9139c8f8d" target="_blank" rel="noopener noreferrer">ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.96
                                </span>
                            </div>
                            <div class="article-summary">AbbVie's oncology sales climbed 4.2% in H1 2025 as new drugs offset Imbruvica declines, strengthening its long-term growth outlook....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6a1b98bbbedb7f1c944319ad49c2ce034e8cda2f7b905bfcb8382cc183244b36" target="_blank" rel="noopener noreferrer">Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=70f3dd6c2b69b2c91a5bf2faf1f22e846bf3388610f0401f0532df8a98bdeb6d" target="_blank" rel="noopener noreferrer">AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.88
                                </span>
                            </div>
                            <div class="article-summary">ABBV posts strong phase III alopecia areata data from the second study on Rinvoq. The drug hit $3.7B in H1 sales and is expected to further drive growth in H2....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f690af61c896f046b572e7a954d2d57a40b46fc083063ba8c71308e9bc4c5601" target="_blank" rel="noopener noreferrer">Dividend Champion, Contender, And Challenger Highlights: Week Of August 24</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5dcf821d2d30593fc2820d7594b618c843f9f1451727b984ebba7988f801c1c4" target="_blank" rel="noopener noreferrer">Top Analyst Reports for NVIDIA, Cisco & Linde</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">NVIDIA, Cisco and Linde post strong gains as analysts spotlight AI growth, software expansion and industrial gas leadership....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1191e8eb9b5badc8d79d4254b2bd3e96a213da06403c9dff7f4a5548b03e47f1" target="_blank" rel="noopener noreferrer">How Much Would It Take To Earn $100 A Month From Pfizer Stock</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.59
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It will report its Q3 2025 earnings on Oct. 28. Wall Street analysts expect t...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5f0d4e3653ea97c55f583809b85a56a70ab1e7f461c42e19cffad599586e62e7" target="_blank" rel="noopener noreferrer">Pfizer: sued in Europe by Enanta for patent infringement</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.92
                                </span>
                            </div>
                            <div class="article-summary">US biotech company Enanta Pharmaceuticals announced on Wednesday that it had filed a complaint with the EU's Unified Patent Court against pharmaceutical giant Pfizer, accusing it of infringing a......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=97f1df5f20ae580b6073a385b457d798914fe25c554a3411bb137c3ed9e43f66" target="_blank" rel="noopener noreferrer">Pfizer: Stagnation Is An Investment Opportunity</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Pfizer offers an attractive near-7% dividend yield, appealing for income-focused investors. Find out why PFE stock is a Buy....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=14acf641000636cd127d58df1a7fe9d6a3ddac89f58d68e9d72e003fb9781e10" target="_blank" rel="noopener noreferrer">Pfizer: Shares Are Cheap, But They Could Get Even Cheaper Next Year</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">I remain bearish on Pfizer due to pricing pressures from IRA/340B and a looming 2026 patent cliff, despite Q2 2025 earnings beat....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=26a468193de7bd021b5caf35fcf05380c75519b7984d369a471a769d51208da7" target="_blank" rel="noopener noreferrer">Leaders Come Together to Advance the Industry at Veeva Summit</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.20
                                </span>
                            </div>
                            <div class="article-summary">Veeva Systems (NYSE: VEEV) today announced highlights of its upcoming Veeva R&D and Quality Summit, where leaders across life sciences and Veeva exchange impactful ideas and innovations. BeOne Medicin...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3917d8c809fe11b26faf7e4478690f9279db7b64862ceab671d0b3c00807fa6c" target="_blank" rel="noopener noreferrer">Has Pfizer Inc.'s (NYSE:PFE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer's (NYSE:PFE) stock is up by a considerable 10% over the past three months. We wonder if and what role the......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=18097b6a8916290eb4ec8301b37628cccef34162d50a8a594abcb98ccc38103f" target="_blank" rel="noopener noreferrer">Low Volatility Calls For This Breakout Trade On Pfizer Stock</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Pfizer stock currently trades at very low volatility. That could mean it’s ripe for a breakout trade, like a long strangle....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b2d3563e71b4a5f4a3af88b9e03d3e16afa04b85b3be2d415daa356edef90535" target="_blank" rel="noopener noreferrer">US-EU trade deal impacts on pharma industry more 'manageable' than expected</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.21
                                </span>
                            </div>
                            <div class="article-summary">A trade deal framework between the US and EU is causing less pain than anticipated for pharma....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9aaef2be70e1f2d712f1b47c8b1dce64987548f13e4fff641e2d6a7b53569d78" target="_blank" rel="noopener noreferrer">[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Biologics and Biosimilars Market size & share revenue was valued at a...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=da8218da74029930319739ebbb0c30d124d26fcc06efb5975b893e1b02bdf4e5" target="_blank" rel="noopener noreferrer">Pfizer Inc. stock outperforms competitors on strong trading day</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. stock outperforms competitors on strong trading day...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=89825dcac1b28db6e5a3199e7098e65c6ea1b5887988ff259bd9db4a253592ae" target="_blank" rel="noopener noreferrer">Padcev-Keytruda combo approved for NHS use in mUC</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.24
                                </span>
                            </div>
                            <div class="article-summary">The combination will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c63bf466a0cc03c9076b93c0386cd28383476ecfc874d2d33ab9e8f8059db064" target="_blank" rel="noopener noreferrer">Latest Fed cut signals, pharma relief rally, Apple TV+ price hike</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.75
                                </span>
                            </div>
                            <div class="article-summary">Yahoo Finance's John Hyland outlines three of the top stories on Wall Street as part of the Market Minute. Federal Reserve Bank of Cleveland President and CEO Beth Hammack tells Yahoo Finance at the J...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=553daaef00be0bcf4df65fc8ffe0ab4cd106e538004997a9f4aa76d090824d89" target="_blank" rel="noopener noreferrer">Enanta Files Patent Lawsuit Against Pfizer (PFE) Over COVID-19 Drug Paxlovid</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-21</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.17
                                </span>
                            </div>
                            <div class="article-summary">Enanta Pharmaceuticals has initiated legal action against Pfizer (PFE) over a patent infringement related to Paxlovid, targeting the company's operations across the EU. Over the last quarter, Pfizer's...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c3907d374789a13bcc0a4f263b16cfc191ed507efec252bde9661f419a70bf5a" target="_blank" rel="noopener noreferrer">Pharmaceuticals Industry Analysis:  Eli Lilly Tops My Tier Two</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.36
                                </span>
                            </div>
                            <div class="article-summary">Tier-two pharma picks show solid fundamentals, but Eli Lilly (LLY) stock stands out for its growth potential. Read here for an analysis....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e9dedffdb3ea0710de12dd6a000cd91acf17d3e949efbea4fa4ab31853269f1b" target="_blank" rel="noopener noreferrer">2 S&P 500 Stocks to Own for Decades and 1 We Ignore</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headw...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bc164b93d0bc0e5004387ca5e43984b3ce156ba8d40aad307a47b5fb34d87386" target="_blank" rel="noopener noreferrer">Enata Sues Pfizer Over Paxlovid Covid-19 Drug</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.93
                                </span>
                            </div>
                            <div class="article-summary">Enata Sues Pfizer Over Paxlovid Covid-19 Drug...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d3ee851073d969dd3f31c153e8fb493257c6a8099a9c15ebbd3c02f13d319dc5" target="_blank" rel="noopener noreferrer">My Top Dividend-Paying, Deep-Value Stock to Buy in August</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">You won't find many stocks with a juicier dividend and more attractive valuation than this big pharma stock....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b401d948d1f82985a104e8fb2bfbb784f8c8a602a4a49ef509f67e1943ca651d" target="_blank" rel="noopener noreferrer">Enata Sues Pfizer in European Union Over Paxlovid Covid-19 Drug -- Update</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.91
                                </span>
                            </div>
                            <div class="article-summary">Enata Sues Pfizer in European Union Over Paxlovid Covid-19 Drug -- Update...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f97faf149ff51f2f9de766a926003f8939b46dd0461cb3cb11fe58101873da0e" target="_blank" rel="noopener noreferrer">Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.36
                                </span>
                            </div>
                            <div class="article-summary">WATERTOWN, Mass., August 20, 2025--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immuno...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=20d39b5f35afe6cce3e909d2349678795903093ada48bbb6a9061a93ae5230c7" target="_blank" rel="noopener noreferrer">S&P 500: Sick Puppies Dominate, But Here's A Trio Of A-List Stocks To Consider</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Discover why the S&P 500 conceals stock weaknesses & explore 3 healthcare picks from a data-driven analysis....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0af53cec36039541f9708e2eac7ef45af4cdb44d708cd5633c7e6343a6257c0f" target="_blank" rel="noopener noreferrer">Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c34d1de9a1638d8341e807efca381201da1b25ec1cee598b7c6f7bfdaa952ebd" target="_blank" rel="noopener noreferrer">Pfizer battles another Paxlovid lawsuit from Enanta</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.13
                                </span>
                            </div>
                            <div class="article-summary">Pfizer says it is “confident” in the intellectual property for its billion-dollar Covid-19 pill Paxlovid....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c8f3dafce4ea1eeebf6d97b2299baef6ecacd9beb6e91a65f5a99c83ba350dee" target="_blank" rel="noopener noreferrer">Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.96
                                </span>
                            </div>
                            <div class="article-summary">Veeva Systems (VEEV) is likely to post fiscal Q2 results that come in line to better and maintain it...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4845f5d3e41b2b80d5b0417187f95106df29e465f10b586b9de78378808ccde2" target="_blank" rel="noopener noreferrer">Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.38
                                </span>
                            </div>
                            <div class="article-summary">Pfizer's yield is high, and so too is its payout ratio....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c33da0c7b44f16f27f94fda5e96d4c1677e0e8b5ae1e99ef81bd9e5528e89ae1" target="_blank" rel="noopener noreferrer">Pfizer Canada and HPIC Mark 30 Years of Humanitarian Partnership Delivering Global Health Impact</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.88
                                </span>
                            </div>
                            <div class="article-summary">On World Humanitarian Day, Pfizer Canada is proud to mark 30 years of partnership with Health Partners International of Canada (HPIC), a collaboration that has delivered over $70 million worth of life...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fca0310c9ec21b09e39ec0df49e4f42da96d9936a969295f6cab3a75caca72c2" target="_blank" rel="noopener noreferrer">Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer's oncology portfolio, boosted by Seagen and strong drug sales, fuels Q2 growth and positions the company for future cancer treatment gains....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a93944426207fe53890998fe6a58e292b9f48b1e48558193c5d4b7f2a2d411e9" target="_blank" rel="noopener noreferrer">MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.91
                                </span>
                            </div>
                            <div class="article-summary">Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung cancer....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=96a92555eb931a1fd445550ee30c63b605bf8ef5244cf12fbab51eb2ce3073b2" target="_blank" rel="noopener noreferrer">3 Defensive Stocks That Can Weather Any Recession</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Dividend stocks are often considered safe haven or defensive stocks that can safeguard a portfolio in turbulent times....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=aa2dc6139f88b4883e2b70b5b376cd2a93f88a80fab08d217abac028ca3b44f2" target="_blank" rel="noopener noreferrer">Arvinas, Pfizer’s Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.43
                                </span>
                            </div>
                            <div class="article-summary">Arvinas Inc. (NASDAQ:ARVN) is one of the best small cap stocks with biggest upside potential. On August 8, Arvinas, in collaboration with Pfizer Inc. (NYSE:PFE), announced that the US FDA accepted its...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ee0d69f2fb0a37f376f98f52ebde4380db21b4bbf19871476475e10dbf90de5b" target="_blank" rel="noopener noreferrer">These 3 Dividend Stocks Have Yields Above 5%, Plus They Raise Their Payouts Every Year</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">These three businesses have been raising their payouts for at least 16 consecutive years....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b7c488352d95b21ae561caaf1adda8cd50aa73790382f3a953a87494c9107d0d" target="_blank" rel="noopener noreferrer">Wall Street Lunch: Wedbush Adds CRWD, RBLX, GEV, NBIS To IVES AI 30 List</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Wedbush added CrowdStrike, Roblox, GE Vernova and Nebius to its IVES AI 30 list....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=28785fc38fa0d26443a3e2d65befbd64c78315528cefd3d208c5cb7110af4bb4" target="_blank" rel="noopener noreferrer">Pfizer’s sickle cell disease candidate fails Phase III trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.43
                                </span>
                            </div>
                            <div class="article-summary">This is the latest hit for Pfizer’s sickle cell disease portfolio after pulling Oxbryta from the market in 2024....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d13750dc14dcc55504e5912e2beae5eb0e423d66db93012afdf15dec56c5709d" target="_blank" rel="noopener noreferrer">Pfizer Canada, BioNTech Get Canadian Approval for Updated Covid-19 Vaccine</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.72
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Canada, BioNTech Get Canadian Approval for Updated Covid-19 Vaccine...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=455ad90336aa24b570fa5874a617716f49404aadd3b4b3b3c3a74f384fce9fd6" target="_blank" rel="noopener noreferrer">Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.67
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY® COVID-19 vaccine for individuals aged 6 months and o...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=339721c7f4e3c6440857653af9951f41c27c25d054a1db12c093c54d9fa0d4f6" target="_blank" rel="noopener noreferrer">Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral’ Rating</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-17</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">With strong hedge fund interest and a low price-to-earnings ratio, Pfizer Inc. (NYSE:PFE) secures a place on our list of the 10 Most Undervalued Value Stocks to Buy Now. Following the company’s strong...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a48e5e746aeace32d093c50284cdc32e4b2b07862cb94bbcff2c5a43a31fe6f0" target="_blank" rel="noopener noreferrer">Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-17</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.45
                                </span>
                            </div>
                            <div class="article-summary">Merck & Co., Inc. (NYSE:MRK) is included in our list of the 10 Most Undervalued Value Stocks to Buy Now. On August 12, 2025, Merck & Co., Inc. (NYSE:MRK) announced an update regarding its Phase 3 KEYN...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5669c6603a4581cb3a47182464b01980192c8fe0b301f23507140e511a6604c8" target="_blank" rel="noopener noreferrer">Beam Therapeutics: A Slow-Developing Story</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-17</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">Beam Therapeutics' base editing tech shows promise in sickle cell & AATD....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5579e7d3add5a2540a790b1ce8ec432d32dfd291c6685c110ce3e14f1d8d361d" target="_blank" rel="noopener noreferrer">Pfizer: This Is What Bulls Waited For</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-16</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.54
                                </span>
                            </div>
                            <div class="article-summary">Pfizer beats Q2 estimates with $14.7B revenue and $0.78 EPS. Management showed extreme confidence by raising full-year EPS guidance. See more on PFE stock here....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d84e19acec31bca5d099a537c7082d41940067e69c75acd81fd8a9362463c460" target="_blank" rel="noopener noreferrer">2 Top Dividend Stocks to Buy on the Dip</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-16</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">These blue chip healthcare stocks could still deliver strong long-term returns....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=aa19266b858c0945a50522cbf629983a42da93f6faab5af6208edaef21b6cce7" target="_blank" rel="noopener noreferrer">Merck KGaA ventures into new territory in the US</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.33
                                </span>
                            </div>
                            <div class="article-summary">How the president of EMD Serono, Merck KGaA, Darmstadt, Germany’s U.S. arm, is leading the charge to “double down” on new innovation....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=22f1af567608854d9850f5e078fc9d4cf87f60d2d3f7e71676d3dbefd1bee734" target="_blank" rel="noopener noreferrer">After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer beat expectations last quarter and it raised its guidance....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fd014a9f6d755d6b46e4d2217832fb0a3807d96f8c3643341f15db4f7b00b5bc" target="_blank" rel="noopener noreferrer">Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b6c049ae34e94860ded0c5cc034fc7400f2633e1748557e57266cf8824ab9f1f" target="_blank" rel="noopener noreferrer">S&P 500: Profit Margins Cannot Hold</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.37
                                </span>
                            </div>
                            <div class="article-summary">Discover how tariff policies and extreme valuations are impacting S&P 500 sectors. Click for my strategy and analysis of various sectors in the current environment....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8c7ecaa4347c659d636f57fb74c8536477449124626665b52fa7ca9f7ad73eeb" target="_blank" rel="noopener noreferrer">AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=858c632a9b7797ea6f19fc63e9aa2cb46fc2e8e4e0cf66cb420301388d48c74a" target="_blank" rel="noopener noreferrer">Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.25
                                </span>
                            </div>
                            <div class="article-summary">We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)’s sha...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e648541a1fdef3b7c8f532dcc7dabef45ee06cc247753bd47fc43993154e930d" target="_blank" rel="noopener noreferrer">Pfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently discussed. Pfizer Inc. (NYSE:PFE)’s shares jumped b...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7ede2251f91bf9e2d54ddb933553fa689bf92972b927da2349a5650f3035911e" target="_blank" rel="noopener noreferrer">Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-14</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d62f5e2fc2faf8e7ecfb7e7c1a56aa486f97519b966592d178940d9f327438f8" target="_blank" rel="noopener noreferrer">If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-14</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, and sells biopharmaceutical products in the U.S. and internationally. It is set to report its Q3 2025 earnings on Oct. 28. Wall Street analyst...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0a0c25000ccf88a8e75b19ea418f65e079e6a7c9f145163cc59ed420d4e24d54" target="_blank" rel="noopener noreferrer">Eli Lilly to hike U.K. Mounjaro Price 170% after Trump push</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-14</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.33
                                </span>
                            </div>
                            <div class="article-summary">The pharmaceutical giant said prices in Europe will need to rise to bring them down in the U.S., following demands by President Donald Trump...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=22cbcd1b1f1fdda2a94fa106e83165a79c58676fd1c3e18da9fbef08a7120f22" target="_blank" rel="noopener noreferrer">The Top 5 Analyst Questions From Pfizer’s Q2 Earnings Call</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.58
                                </span>
                            </div>
                            <div class="article-summary">Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for both revenue and non-GAAP earnings. Management attributed this performance ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=403228885a2adfc53f47e1733d9a98a0b6bd7c6bf95064faddd366ca4f5e8800" target="_blank" rel="noopener noreferrer">PFE Q2 Deep Dive: Margin Expansion and R&D Pipeline Fuel Outlook Amid Policy Uncertainty</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.77
                                </span>
                            </div>
                            <div class="article-summary">Global pharmaceutical company Pfizer (NYSE:PFE) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.3% year on year to $14.65 billion. The company expects the full ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=642c79a5d7ace207c9d722f9b6e969419b05a47cf1edf5c3505e32f7b283a55b" target="_blank" rel="noopener noreferrer">My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">See here for more on July's investment insights: record-breaking dividends, high-yield BDCs, and strategies for steady income growth....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a4203c5863e99190c67e881ce663ad3a8288427cd1e774ec828df14b8dfc7fa7" target="_blank" rel="noopener noreferrer">3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.77
                                </span>
                            </div>
                            <div class="article-summary">This big pharma company's juicy dividend is looking even more attractive....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=39c0d26d75f4c4c0cfdc73fdb5edb4a2c3b5734d2b172198bc861833bff60f4f" target="_blank" rel="noopener noreferrer">Will Zanzalintinib Ease Out EXEL's Reliance on Cabometyx for Growth?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Exelixis reports strong phase III results for zanzalintinib in metastatic colorectal cancer, raising hopes beyond Cabometyx....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=016bf5ea612edf87ebda38b794a7bda822ac8a84d056d2e01aedd09cb5f7de92" target="_blank" rel="noopener noreferrer">Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">The Saudi Arabia Osteoporosis Drugs Market is projected to grow from US$ 210.89 million in 2024 to US$ 308.84 million by 2033, with a CAGR of 4.33% from 2025. Major growth drivers include an aging pop...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=965deccd71c67a3f71337fd48941065968808710f7e06264f5ee8bf6b4bf13f5" target="_blank" rel="noopener noreferrer">July Readers Tagged 9 Ideal Dividend Dogs From 17 "Safer" Of 40 ReFa/Ro Mentions</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.28
                                </span>
                            </div>
                            <div class="article-summary">Read about the investment insights from top-yield and high-gain stocks mentioned by our readers....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fc34bd02b561cc23d347c73a5fc0ed358595397e717c9f6c0f387df98221725b" target="_blank" rel="noopener noreferrer">Should You Now Consider Selling Your Pfizer (PFE) Shares Before its Too Late?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.46
                                </span>
                            </div>
                            <div class="article-summary">Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor let...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b59a7382ab24ae320a1dd9379168cb43dbb8939d95b9279b31facd1b3f8ca225" target="_blank" rel="noopener noreferrer">PFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer's new and acquired drugs record sales of $4.7B in H1 as COVID-products related volatility eases....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6507ba371cc51c7de41ba0e6e19f0442536b98398c4b536baeaff240ff265aa6" target="_blank" rel="noopener noreferrer">Pfizer (PFE) Reports Promising Phase 3 Results For Bladder Cancer Treatment Combination</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Pfizer (PFE) recently announced positive topline results from the Phase 3 EV-303 clinical trial, showcasing promising outcomes for PADCEV in treating muscle-invasive bladder cancer. Over the last quar...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=440fad085cf53a8790a8af52af9f5736b855cd944afaef7eea3803fcb1e30bbe" target="_blank" rel="noopener noreferrer">Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.32
                                </span>
                            </div>
                            <div class="article-summary">It was a rare breath of fresh air for shareholders....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6a6b1e3b69310e1c3bf3525f4788126b8d5848604c9a1f6b0c4b464d14d703e5" target="_blank" rel="noopener noreferrer">Pfizer Reports Positive Topline Phase 3 Results For HYMPAVZI™ In Hemophilia A or B With Inhibitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. (NYSE:PFE) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Pfizer Inc. (NYSE:PFE) reported positive topline results from its Phase 3 BASIS study, which evaluated HYMPAVZI™ ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=90ab588c57d2dbc327b6a7e8b9b78710122a1202d8783848ba5bfd9861ad7677" target="_blank" rel="noopener noreferrer">If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Investing is about looking ahead....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=dc65ae83c1a5efb04c24fb802e3932778cb143c9644f51a4bff8f7c3ab0d7c0f" target="_blank" rel="noopener noreferrer">Merck, Pfizer, Astellas Drug Combo Hits Key Goals in Bladder Cancer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">Merck, Pfizer, Astellas Drug Combo Hits Key Goals in Bladder Cancer...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=83e43a8fb53e74d57eaca6e72cf462ef320b46d8e3a10d310986d46160980737" target="_blank" rel="noopener noreferrer">PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.91
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK & TOKYO, August 12, 2025--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the Phase 3 ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=935f341a4411b701496e42970e26df9cbaf2110b44122724cea5bef64808ce44" target="_blank" rel="noopener noreferrer">Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">The Global Multiple Myeloma Market is projected to grow from USD 21.78 billion in 2024 to USD 40.41 billion by 2033, at a CAGR of 7.11%. Growth drivers include rising multiple myeloma cases, advances ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4e71c05e2033b944559e6e7590c87eb6f7f1c2dc9d8b45e9173f01147e7e8a07" target="_blank" rel="noopener noreferrer">Statutory Profit Doesn't Reflect How Good Pfizer's (NYSE:PFE) Earnings Are</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NYSE:PFE 1 Year Share Price vs Fair Value Explore Pfizer's Fair Values from the Community and select yours Pfizer......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e1ccabd77be1e044fad8023ad6b17165eae0df32b7fe79d9e3c507041c3f2f15" target="_blank" rel="noopener noreferrer">Former Pfizer Chief Scientific Officer joins MC Sciences as Independent Chairman</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">MC Sciences, an emerging biotech developing first-in-class novel therapeutics backed by ROC Venture Group, proudly announces the appointment of Dr. Mikael Dolsten, former Worldwide Chief Scientific Of...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c726f113507eda77bf53434a0a9a19d38c4f234b54e5296b1b85e44c1d6751d4" target="_blank" rel="noopener noreferrer">Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">On Tuesday, Merck & Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=57ffee763b6320d47ff71751927d6f006b0b6b56a1e470cdfc257053fff5acb7" target="_blank" rel="noopener noreferrer">The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer beats Q2 estimates with rising oncology sales, new drug launches, and strong Seagen-driven portfolio growth....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=16584c7e63fc97a940909a82e17bc930b623d0b60616a2651204bdd401d7650f" target="_blank" rel="noopener noreferrer">SMMT Q2 Loss Wider Than Expected, Ivonescimab Studies in Focus</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.93
                                </span>
                            </div>
                            <div class="article-summary">Summit Therapeutics posts wider-than-expected second-quarter loss as ivonescimab trials advance in multiple lung cancer settings....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=baf9066a6718b608fcbe28608089e0041ab58e84a9b52514af373a34b778d53a" target="_blank" rel="noopener noreferrer">Perioperative Padcev and Keytruda improves survival in MIBC</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.87
                                </span>
                            </div>
                            <div class="article-summary">In the Phase III trial, the combination improved event-free survival and overall survival....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=aab6e600d69197906c62f24023c238ee248c3666ccb22b2c00f7b3189a8b8335" target="_blank" rel="noopener noreferrer">Pfizer Raises Its Guidance and Analysts Up Their Targets - PFE Stock Looks Cheap</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.24
                                </span>
                            </div>
                            <div class="article-summary">Pfizer stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just over 8x this year's estimates and 7.8x next year. That's too cheap. Shortin...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bfebd0efd179940dadf87b57e531a8d51a16592d887cd213b09263ea868d7326" target="_blank" rel="noopener noreferrer">Pfizer (PFE) Reports Positive Phase 3 Results In Bladder Cancer Treatment Study</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Pfizer (PFE) recently announced positive results from its Phase 3 EV-303 clinical trial in collaboration with Astellas Pharma, showing significant improvements in event-free and overall survival for b...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=44898670113173f3eb11866417ec12fa9fc2e67d687993d71e9d0fda80d82bb4" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Advance in Afternoon Trading</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.86
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Health Ca...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=814f7cfc8ccad44d28389089aa5ae434453c5cf879cd550b88696b2ed75de88f" target="_blank" rel="noopener noreferrer">Industry Leader in Lyophilization, Dr. Serguei Tchessalov, Partners with BioTechnique® to Enhance Customer Capabilities</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.80
                                </span>
                            </div>
                            <div class="article-summary">YORK, Pa., August 12, 2025--BioTechnique® LLC ("BioTechnique" or the "Company") proudly welcomes Dr. Serguei Tchessalov, a globally recognized subject matter expert in lyophilization, whose decades of...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=745bb827fe673cde00141841e0b984a262f0952485492642e296bc0d7cabad8f" target="_blank" rel="noopener noreferrer">AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-12</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.33
                                </span>
                            </div>
                            <div class="article-summary">Pharmaceutical company AbbVie announced Tuesday that it will construct a new $195 million facility near its headquarters in North Chicago, Illinois. AbbvVie is one of the largest biomedical companies ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9c1ab6fb3a17c7cb54c0ffffcdb29f9fcbfc4ec2c605f7657ce41748e757ab9e" target="_blank" rel="noopener noreferrer">GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">Investing.com -- GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review application for gepotidacin, an oral antibiotic aimed at treating s...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7ed66726fb860b103f275cf311c614095bcaca667705b72b586e98df5fdd96f9" target="_blank" rel="noopener noreferrer">Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.49
                                </span>
                            </div>
                            <div class="article-summary">The Non-metastatic Prostate Cancer market is witnessing substantial growth driven by increasing demand for targeted therapies and innovative treatment options. Non-metastatic prostate cancer, confined...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cfcbe961aab7a34b58162c11b9729aac28e51a919803dc23fd1bd6bd3492c527" target="_blank" rel="noopener noreferrer">FDA gives Arvinas and Pfizer’s vepdegestrant NDA for breast cancer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Vepdegestrant is an investigational, oral bioavailable PROteolysis TArgeting Chimera (PROTAC) medication....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9b792f2d80db8c118ae6948862869b5f26d134d3d1926bdd311f297bfab8402d" target="_blank" rel="noopener noreferrer">Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Multiple Myeloma is a cancer affecting plasma cells in bone marrow, often leading to weakened bones, anemia, and kidney damage. The production of abnormal M-proteins is a disease hallmark, detectable ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=657e4b986a3644724c9843d0f2042d9ca363503b15e12a92fd0826893eccf0eb" target="_blank" rel="noopener noreferrer">Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer posts strong Q2 earnings and raises EPS outlook, with oncology growth and new drugs offsetting looming headwinds....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=33e219893e5ff70d5426b444ee5aa22e2dd7a6608d34f9b1f1e8f72f4863156f" target="_blank" rel="noopener noreferrer">Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    -0.01
                                </span>
                            </div>
                            <div class="article-summary">Vertex Pharmaceuticals Incorporated's stock drop is overblown. With strong CF revenue, pipeline potential, & insider confidence, click for why VRTX stock is a Buy....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=579d14adbf7da8c892f4d48a1e7d313d8ed40e4168545fca2a4d0460f278d18b" target="_blank" rel="noopener noreferrer">Meet the 7.3% Yield Dividend Stock That Could Soar in 2026</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.32
                                </span>
                            </div>
                            <div class="article-summary">This stock recently bounced on strong Q2 earnings, and the fun could be just getting started....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1827b83649cbfa86683f1c377380125ccca265eaac9c26c6891d9ab9181a607e" target="_blank" rel="noopener noreferrer">2 Beaten-Down Stocks to Buy and Hold</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The market has been tough on these stocks, but a closer look at each is warranted....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=698cc81d4da0690969c1d64f7102d317cce83a3810db6a9754f653b43b173866" target="_blank" rel="noopener noreferrer">FDA Accepts Pfizer (PFE) Vepdegestrant NDA for Breast Cancer, Fast Track Designation Awarded</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-09</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.91
                                </span>
                            </div>
                            <div class="article-summary">Pfizer (PFE) recently announced that the U.S. Food and Drug Administration accepted the New Drug Application for vepdegestrant, offering potential new treatment options for certain breast cancer patie...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=563d858fabe962b4dba707b6e7fc3ef7d7f75b367717a664afd722f9e299debb" target="_blank" rel="noopener noreferrer">Pfizer (PFE) Releases Financial Results for Q2 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On August 5, the company released its financial results for Q2 2025 and reaffirmed the 2025 reve...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0932e525196675373d445d490847f8421b434db2d33bdeeb687a1dee51fe3240" target="_blank" rel="noopener noreferrer">GSK to Receive $370 Million in U.S. Patent Litigation Settlement</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.03
                                </span>
                            </div>
                            <div class="article-summary">The pharma giant will also receive a 1% royalty on future U.S. sales of influenza, Covid-19 and other related combination mRNA vaccine products made by BioNTech and Pfizer....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=72854c00e6f6d1c9c2d713cff66f2eb0e69c3b9f2257d09eec1accf38140180b" target="_blank" rel="noopener noreferrer">Trending tickers: Nvidia, Intel, The Trade Desk, Pinterest and GSK</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The latest investor updates on stocks that are trending on Friday...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5f4a7a1a8ef7c1a98d610201ab091059caa294551e8af11f30b453638c4e2d79" target="_blank" rel="noopener noreferrer">GSK to be paid up to £370 million after patent row settles in US</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.30
                                </span>
                            </div>
                            <div class="article-summary">CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on Thursday....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=633c026ef7e7ca1e0f9add8f09e920f2d5852427d3184d08ffdd2e8066ad8c96" target="_blank" rel="noopener noreferrer">GSK to Receive $370 Million From CureVac, BioNTech Patent Dispute Settlement</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.63
                                </span>
                            </div>
                            <div class="article-summary">GSK (GSK) said Friday that it will receive $370 million from the mRNA patent settlement deal between...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fdafbf55b828db568f5f34144c6ca9dacd87d2a95a28ecc94ec96020bd082e72" target="_blank" rel="noopener noreferrer">BioNTech ends patent fight with mRNA rival CureVac ahead of buyout deal</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.17
                                </span>
                            </div>
                            <div class="article-summary">The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an acquisition of its one-time COVID-19 vaccine competitor....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=605a210f5f4851711d50b836243607b7cde31069c371bcc16fed56f77cced7cf" target="_blank" rel="noopener noreferrer">Tariffs Be Damned. Stocks Flirt With a New Record High.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.74
                                </span>
                            </div>
                            <div class="article-summary">Tariffs Be Damned. Stocks Flirt With a New Record High....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=81404eea55a3f2d53c7745ab8cf969aa59f2226e14b2dbfb461cb088f20d4d08" target="_blank" rel="noopener noreferrer">Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Abbott outpaces market trends as EPD sales surge, fueled by double-digit growth, biosimilar approvals and strong product demand....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ad9cce6714ce0520f29a6f709cbf7620898d839ae2612a920168375e2d89ba27" target="_blank" rel="noopener noreferrer">Top Midday Stories: Trade Desk CEO Says Tariffs Impacting Key Clients; UK Regulator Approves Boeing's Acquisition of Spirit AeroSystems</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.20
                                </span>
                            </div>
                            <div class="article-summary">All three major US stock indexes were up in late-morning trading Friday and are poised to secure a w...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=461cdeebf40fd6ea3b8714bd3e31e95053cf3c58970b50e69ba358b71f96dd55" target="_blank" rel="noopener noreferrer">EpiPen patent expiry opens new era for innovation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.54
                                </span>
                            </div>
                            <div class="article-summary">The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in the epinephrine delivery space....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c8d7afd3cad318e005e921756e67ff1de4e039dfebea9bb23a476b8624623810" target="_blank" rel="noopener noreferrer">Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.88
                                </span>
                            </div>
                            <div class="article-summary">– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant – – Vepd...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=49c42cfb308f54470ab4efe576f4d8f4f3d7b35afc8c13945afcbef377c50990" target="_blank" rel="noopener noreferrer">The Score: Apple, Palantir, Intel and More Stocks That Defined the Week</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">Tech giants rallied Wednesday after Trump announced tariff exemptions for tech companies investing in U.S. production.  The announcement came at an event trumpeting Apple’s new $100 billion investment...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0f03d520026c614d24ede15271a65097b8b16bee99ce35105cfafaa51cc17238" target="_blank" rel="noopener noreferrer">Pfizer's Turnaround Has Truly Started (Earnings Update)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.50
                                </span>
                            </div>
                            <div class="article-summary">Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE stock is a Buy....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1a402a66bba670f8d7c87ce1a43fefbb451d6638e7897e7e7d8762a9c9703459" target="_blank" rel="noopener noreferrer">This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Meeting its dividend commitment this year should be a breeze, but the path ahead is much harder to predict....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=037b59eb2d0133eb9a4ca8ec95a2e8eeec7da00d221fc60836d101d8b8dcb4d7" target="_blank" rel="noopener noreferrer">Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.41
                                </span>
                            </div>
                            <div class="article-summary">The smaller market now envisioned for vepdegestrant has changed both companies’ stance on their original deal, leading to negotiations that could either lead to a new alliance or Arvinas to seek a new...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=941ddaff6855a991a20d9423905639cb78835b6465ba4c05e478869f6b2235d4" target="_blank" rel="noopener noreferrer">RFK Jr’s mRNA funding halt signals “shift in US public health”</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.93
                                </span>
                            </div>
                            <div class="article-summary">The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c5faab32289036b61d1de41f603a0cb2c73c4612692dcf7386f42a8f151806d8" target="_blank" rel="noopener noreferrer">United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.31
                                </span>
                            </div>
                            <div class="article-summary">The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a CAGR of 4.86% (2025-2033). Growth is driven by rising chronic diseases, demand...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a3c949f863a6b4b6fd050851bb0dfe742b06154922c54082d4e792b0073a4c40" target="_blank" rel="noopener noreferrer">United States Vaccines Market Insights and Forecasts 2024 & 2025-2033 | Rising Infectious Disease Burden, Robust Funding and Regulatory Support Accelerate Innovation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.36
                                </span>
                            </div>
                            <div class="article-summary">The US vaccines market, valued at $29.5B in 2024, is projected to reach $60B by 2033, at a CAGR of 8.2%. Key growth drivers include rising infectious diseases and biotech advancements. Comprehensive a...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=55c7cc77d1fd20de5684daa8ba9a18267a9e8f07b6b81697e00ce172515607a7" target="_blank" rel="noopener noreferrer">Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">The global influenza vaccine market is on a growth trajectory, driven by heightened awareness about vaccination's role in preventing contagious diseases like influenza. In light of recent pandemics, f...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=91649a458388fbea93b6f363e1c0ddb5e37f22a62a618bf64a6059171d2f23fc" target="_blank" rel="noopener noreferrer">Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.31
                                </span>
                            </div>
                            <div class="article-summary">Global Cancer Antibody Drug Conjugates Market poised to exceed USD 70 billion by 2031, driven by over 20 approved drugs. Report offers insights into market size, sales, pricing, and clinical trials wi...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9a8e4064a99bde35e95e225106c6771e3156aa6b8dc50846fccc1e9bb0a4e06f" target="_blank" rel="noopener noreferrer">Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.84
                                </span>
                            </div>
                            <div class="article-summary">Healthcare stocks have been the sick man of the  this year.  The  exchange-traded fund has fallen 3.7% this year, far worse than the S&P 500’s 7.1% rise.  The ETF includes everything from insurers to ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9269745b3bba3f670affceaba93a9c88b7bbfb079cfd62c8fa83adf69b6aa039" target="_blank" rel="noopener noreferrer">Pfizer Pops Despite Looming Pharma Tariffs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.17
                                </span>
                            </div>
                            <div class="article-summary">The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US patients....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=294cfc2940509d17e0297bab8434380ebca59456f5886d62a0a1aa2d4679fa4d" target="_blank" rel="noopener noreferrer">US Health Department Ending Federal mRNA Vaccine Development</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.31
                                </span>
                            </div>
                            <div class="article-summary">The US Health and Human Services Department said Tuesday it will soon end federal mRNA vaccine proje...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b729a29cadc5dd856c690e4cf2c0041d0c38a93a2b3bf6dd793411689b6e252f" target="_blank" rel="noopener noreferrer">1 Reason to Buy Pfizer (PFE) Stock</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">How does $740 in annual income sound?...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=81dd0d826d6f6812e60b3ec1bcfc074c25af74a0a930194d420e3897b3f20dc5" target="_blank" rel="noopener noreferrer">Nxera debuts an obesity pipeline; BridgeBio battles Alnylam for market share</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.36
                                </span>
                            </div>
                            <div class="article-summary">The company formerly known a Sosei Heptares unveiled new weight loss programs. Elsewhere, BridgeBio and Madrigal unveiled sales numbers for their chief drugs....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b568f88be98b7cfabd8474ab247cde2001ac275311ef45c4210e3ed0e9c80a55" target="_blank" rel="noopener noreferrer">Pfizer Second Quarter 2025 Earnings: Beats Expectations</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Pfizer ( NYSE:PFE ) Second Quarter 2025 Results Key Financial Results Revenue: US$14.7b (up 10% from 2Q 2024). Net......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3f3c0427ee8360691a66d41e168fa554ace4c2c8aa1e153e9298eec25c004256" target="_blank" rel="noopener noreferrer">BMY Stock Trades Near 52-Week Low: Time to Buy or Sell?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.85
                                </span>
                            </div>
                            <div class="article-summary">BMY trims earnings outlook despite revenue beat and upbeat drug sales, sending shares to a 52-week low before a rebound. We recommend investors to stay on the sidelines for now....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4e47a65dd7f12cd5e851fc597161ea56befc0a92285c37becd931feb0f1007b6" target="_blank" rel="noopener noreferrer">Company News for Aug 6, 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Companies in The News Are: PFE,MPC,CMI,GLDD...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4f3a4c744d7d840e27ca592b28942369d8e6c776772a471498811a2b5f23c37c" target="_blank" rel="noopener noreferrer">Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.24
                                </span>
                            </div>
                            <div class="article-summary">Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=172946174033ef2b96e42b9534e548891ec5931780da9988fd9689f72043f1e7" target="_blank" rel="noopener noreferrer">Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.91
                                </span>
                            </div>
                            <div class="article-summary">Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=15b27f8be9cdee07f1201d2a66fe597c803cb469e98d06d061807b32730ac880" target="_blank" rel="noopener noreferrer">Pfizer CEO says has spoken with Trump, in ‘productive’ talks with government</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.35
                                </span>
                            </div>
                            <div class="article-summary">On the company’s Q2 earning call, Pfizer (PFE) noted that the company’s guidance “absorbs the impact of the currently imposed tariffs from China, Canada and Mexico as well as potential price changes t...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a07cde59a28ecf96ff2648c948f0086e1fc63cd06780194bd984debeec7af54b" target="_blank" rel="noopener noreferrer">RFK Jr. Ordered the HHS to Stop Funding mRNA Vaccine Development. The Edict Hit a Biotech Working on an Unrelated Treatment.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">RFK Jr. Ordered the HHS to Stop Funding mRNA Vaccine Development. The Edict Hit a Biotech Working on an Unrelated Treatment....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7f6f938231eee2b025b3a1245fcb7e0f2a0633aeb2f092ca1f80fa00383f0fc3" target="_blank" rel="noopener noreferrer">Pfizer Q2: Dividends Speak Louder Than EPS</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate PFE stock a Sell....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=3949aea2e1c4d514e9fd11aa2566e4275e1c0417bd972ca957b5538b9b702c47" target="_blank" rel="noopener noreferrer">Chai Discovery Announces $70 million Series A To Transform Molecular Design</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.26
                                </span>
                            </div>
                            <div class="article-summary">SAN FRANCISCO, August 06, 2025--Chai Discovery, the AI company that predicts and reprograms the interactions between biochemical molecules to accelerate life-changing therapeutics, today announced its...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        